BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 1375473)

  • 1. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of immunosuppression.
    Baumann G; Zenke G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    J Autoimmun; 1992 Apr; 5 Suppl A():67-72. PubMed ID: 1380246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE; Schreiber SL; Burakoff SJ
    Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression.
    Heitman J; Movva NR; Hall MN
    New Biol; 1992 May; 4(5):448-60. PubMed ID: 1515410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of FK-506 and cyclosporin A.
    Wiederrecht G; Lam E; Hung S; Martin M; Sigal N
    Ann N Y Acad Sci; 1993 Nov; 696():9-19. PubMed ID: 7509138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunosuppressive macrolides FK-506 and rapamycin.
    Thomson AW
    Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A: new insights for cell biologists and biochemists.
    Hohman RJ; Hultsch T
    New Biol; 1990 Aug; 2(8):663-72. PubMed ID: 2282365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
    Zarnt T; Lang K; Burtscher H; Fischer G
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
    Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
    Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.